The Association of Anti-CCP Positivity with Extra-Articular Manifestations in Patients with Rheumatoid Arthritis

Anti-Cyclic Citrullinated Peptide Positivity and Extra-Articular Rheumatoid Arthritis

Authors

  • Najib Ullah Department of Rheumatology, Khyber Teaching Hospital Peshawar, Peshawar, Pakistan
  • Abdul Waris Department of Rheumatology, Lady Reading Hospital Peshawar, Peshawar, Pakistan
  • Alam Zeb Department of Rheumatology, Khyber Teaching Hospital Peshawar, Peshawar, Pakistan
  • Muheebur Rehman Department of Allied Health and Biological Science, Abasyn University Peshawar, Peshawar, Pakistan
  • Shawkat Ali Department of Pathology, Khyber Teaching Hospital Peshawar, Peshawar, Pakistan
  • Muhammad Imran Department of Rheumatology, Khyber Teaching Hospital Peshawar, Peshawar, Pakistan
  • Zahid Muhammad wazir Department of Medicine, Khyber Teaching Hospital Peshawar, Peshawar, Pakistan

DOI:

https://doi.org/10.54393/pbmj.v7i07.1098

Keywords:

Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, Autoimmune Diseases, RA Disease Activity Score

Abstract

Rheumatoid Arthritis (RA) is an autoimmune inflammatory disorder that primarily affects the joints. Objective: To examine association between anti-cyclic citrullinated peptide and extra-articular manifestation of Rheumatoid arthritis. Methods: It was a descriptive cross-sectional study in the Department of Rheumatology outpatient Khyber Teaching Hospital in Peshawar from 13th April 2023 to 13th September 2023. A descriptive cross-sectional study was conducted on 100 patients diagnosed with rheumatoid arthritis according to ACR/EULAR 2010 criteria at the Rheumatology outpatient department of Khyber teaching hospital in Peshawar from 13th April 2023 to 13th September 2023. Sampling technique was non probability consecutive. Statistical analysis was performed using SPSS version 23.0. Results: Our study involved 100 patients diagnosed with rheumatoid arthritis. Majority of the patients were female (90%) with overall mean age was 42.3 ± 10.06 years. The average duration of the disease was 5.9 years, with a mean RA disease activity score of 2.8. Extra-articular manifestations were observed in 84% of the patients, encompassing various symptoms such as anemia, subcutaneous nodules, episcleritis, and interstitial lung disease. Most patients (94%) tested positive for Rheumatoid Arthritis Factor, while 84% tested positive for anti-CCP antibodies. Our analysis revealed significant associations between the presence of extra-articular manifestations and factors such gender distribution, disease activity score and anti-CCP antibody positivity while no significance was noted for factors such as age, Rheumatoid Arthritis Factor and duration of disease. Conclusions: Our study concludes that anti-CCP was positively associated with the presence of extra-articular manifestation of Rheumatoid Arthritis.

Author Biography

Muhammad Imran, Department of Rheumatology, Khyber Teaching Hospital Peshawar, Peshawar, Pakistan

 

 

References

Mun S, Lee J, Park M, Shin J, Lim MK, Kang HG. Serum biomarker panel for the diagnosis of rheumatoid arthritis. Arthritis Research & Therapy. 2021 Dec; 23:1-0. doi: 10.1186/s13075-020-02405-7. DOI: https://doi.org/10.1186/s13075-020-02405-7

Goma SH, Razek MR, Abdelbary NM. Impact of rheumatoid arthritis on the quality of life and its relation to disease activity. Egyptian Rheumatology and Rehabilitation. 2019 Oct; 46:304-12. doi: 10.4103/err.err_39_19. DOI: https://doi.org/10.4103/err.err_39_19

Naqvi AA, Hassali MA, Aftab MT. Epidemiology of rheumatoid arthritis, clinical aspects and socio-economic determinants in Pakistani patients: A systematic review and meta-analysis. The Journal of the Pakistan Medical Association. 2019 Mar; 69(3): 389-98.

Motta F, Bizzaro N, Giavarina D, Franceschini F, Infantino M, Palterer B, Sebastiani GD, Selmi C. Rheumatoid factor isotypes in rheumatoid arthritis diagnosis and prognosis: a systematic review and meta-analysis. RMD open. 2023 Aug 1;9(3):e002817. doi: 10.1136/rmdopen-2022-002817 DOI: https://doi.org/10.1136/rmdopen-2022-002817

Iyengar KP, Vaish A, Nune A. Anti-cyclic citrullinated peptide antibody (ACPA) and Rheumatoid arthritis: Clinical relevance. Journal of Clinical Orthopaedics and Trauma. 2022 Jan 1;24: 101729. doi: 10.1016/j.jcot.2021.101729. DOI: https://doi.org/10.1016/j.jcot.2021.101729

Ljung L, Jönsson E, Franklin J, Berglin E, Lundquist A, Rantapää-Dahlqvist S. Incidence and predisposing factors of extra-articular manifestations in contemporary rheumatoid arthritis. European journal of internal medicine. 2024 May 4. doi: 10.1016/j.ejim.2024.04.026 DOI: https://doi.org/10.1016/j.ejim.2024.04.026

Cheng Q, Chen X, Wu H, Du Y. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis. Journal of translational medicine. 2021 Dec; 19:1-5. doi.org/10.1186/s12967-020-02689-y DOI: https://doi.org/10.1186/s12967-020-02689-y

Díaz Cuña C, Consani S, Rostan S, Fernández L, Moreira E, Sanmartí R. Rheumatoid arthritis: Extra articular manifestations and comorbidities. Revista Colombiana de Reumatología. 2022 Sep; 29(3): 196-204. doi: 10.1016/j.rcreue.2021.03.003. DOI: https://doi.org/10.1016/j.rcreue.2021.03.003

Taylor P, Gartemann J, Hsieh J, Creeden J. A systematic review of serum biomarkers anti‐cyclic citrullinated peptide and rheumatoid factor as tests for rheumatoid arthritis. Autoimmune diseases. 2011 Sep; 2011(1): 815038. doi: 10.4061/2011/815038. DOI: https://doi.org/10.4061/2011/815038

Yasmin R, Sarker HN. Anti-CCP antibody in rheumatoid arthritis patients and its relation with severity of the disease. BIRDEM Medical Journal. 2022; 12(1): 36-40. doi: 10.3329/birdem.v12i1.57223. DOI: https://doi.org/10.3329/birdem.v12i1.57223

Birtane M, Yavuz S, Taştekin N. Laboratory evaluation in rheumatic diseases. World Journal of Methodology. 2017 Mar 3;7(1):1. doi: 10.5662/wjm.v7.i1.1 DOI: https://doi.org/10.5662/wjm.v7.i1.1

Mitroi A, Ionescu AM. Extra-Articular Manifestations in Rheumatoid Arthritis-Predictors of Osteoporosis. Acta Medica Transilvanica. 2021 Dec; 26(4): 50-2. doi: 10.2478/amtsb-2021-0073. DOI: https://doi.org/10.2478/amtsb-2021-0073

Sulaiman FN, Wong KK, Ahmad WA, Ghazali WS. Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients. Medicine. 2019 Mar; 98(12): e14945. doi: 10.1097/MD.0000000000014945. DOI: https://doi.org/10.1097/MD.0000000000014945

ElSherbiny DA. Frequency and predictors of extra-articular manifestations in patients with rheumatoid arthritis. The Egyptian Journal of Hospital Medicine. 2019 Jul; 76(5): 4062-7. doi: 10.21608/ejhm.2019.42300. DOI: https://doi.org/10.21608/ejhm.2019.42300

Shakiba Y, Koopah S, Jamshidi AR, Amirzargar AA, Masoud A, Kiani A, Niknam MH, Nazari B, Nikbin B. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity. Iranian Journal of Allergy, Asthma and Immunology. 2014 Jun; 13(3): 147-56.

van der Woude D, van der Helm-van AH. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Practice & Research Clinical Rheumatology. 2018 Apr; 32(2): 174-87. doi: 10.1016/j.berh.2018.10.005. DOI: https://doi.org/10.1016/j.berh.2018.10.005

Turesson C, O’fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Annals of The Rheumatic Diseases. 2003 Aug; 62(8): 722-7. doi: 10.1136/ard.62.8.722. DOI: https://doi.org/10.1136/ard.62.8.722

De Rycke L, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L et al. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Annals Of The Rheumatic Diseases. 2004 Dec; 63(12): 1587-93. doi: 10.1136/ard.2003.017574. DOI: https://doi.org/10.1136/ard.2003.017574

Rehman M, Ahmad U, Waseem M, Ali B, Tariq MI. Effects of exercise training in patients with lung cancer during chemotherapy treatment. The Malaysian Journal of Medical Sciences. 2023 Apr; 30(2): 141. doi: 10.21315/mjms2023.30.2.13. DOI: https://doi.org/10.21315/mjms2023.30.2.13

Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD, Tanasescu R. Extra-articular manifestations in rheumatoid arthritis. Maedica. 2010 Dec; 5(4): 286.

Downloads

Published

2024-07-31
CITATION
DOI: 10.54393/pbmj.v7i07.1098
Published: 2024-07-31

How to Cite

Ullah, N., Waris, A., Zeb, A., Rehman, M., Ali, S., Imran, M., & Muhammad wazir, Z. (2024). The Association of Anti-CCP Positivity with Extra-Articular Manifestations in Patients with Rheumatoid Arthritis: Anti-Cyclic Citrullinated Peptide Positivity and Extra-Articular Rheumatoid Arthritis. Pakistan BioMedical Journal, 7(07), 29–33. https://doi.org/10.54393/pbmj.v7i07.1098

Issue

Section

Original Article

Plaudit

Most read articles by the same author(s)